Dashboard
Manage Tickers

HAEHAEMONETICS CORP

NYSE haemonetics.com


$ 83.41 $ -2.31 (-2.69 %)    

Tuesday, 25-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 83.42
$ 86.25
$ 0.00 x 0
$ 0.00 x 0
$ 83.28 - $ 86.25
$ 70.74 - $ 97.97
1,060,623
na
4.29B
$ 0.80
$ 36.47
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-20-2024 03-30-2024 10-K
2 02-08-2024 12-30-2023 10-Q
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 07-01-2023 10-Q
5 05-22-2023 04-01-2023 10-K
6 02-07-2023 12-31-2022 10-Q
7 11-08-2022 10-01-2022 10-Q
8 08-10-2022 07-02-2022 10-Q
9 05-25-2022 04-02-2022 10-K
10 02-08-2022 01-01-2022 10-Q
11 11-09-2021 10-02-2021 10-Q
12 08-11-2021 07-03-2021 10-Q
13 05-26-2021 04-03-2021 10-K
14 02-02-2021 12-26-2020 10-Q
15 11-04-2020 09-26-2020 10-Q
16 08-04-2020 06-27-2020 10-Q
17 05-20-2020 03-28-2020 10-K
18 02-04-2020 12-28-2019 10-Q
19 11-01-2019 09-28-2019 10-Q
20 08-06-2019 06-29-2019 10-Q
21 05-22-2019 03-30-2019 10-K
22 02-05-2019 12-29-2018 10-Q
23 11-06-2018 09-29-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-23-2018 03-31-2018 10-K
26 02-06-2018 12-30-2017 10-Q
27 11-07-2017 09-30-2017 10-Q
28 08-07-2017 07-01-2017 10-Q
29 05-24-2017 04-01-2017 10-K
30 02-06-2017 12-31-2016 10-Q
31 11-07-2016 10-01-2016 10-Q
32 08-01-2016 07-02-2016 10-Q
33 06-01-2016 04-02-2016 10-K
34 02-02-2016 12-26-2015 10-Q
35 11-04-2015 09-26-2015 10-Q
36 07-30-2015 06-27-2015 10-Q
37 05-22-2015 03-28-2015 10-K
38 02-05-2015 12-27-2014 10-Q
39 11-04-2014 09-27-2014 10-Q
40 07-31-2014 06-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

haemonetics-announces-a-limited-market-release-of-its-vascade-mvp-xl-vascular-closure-device
Haemonetics Announces A Limited Market Rel...
06/18/2024 20:17:02

haemonetics-strategic-moves-poised-to-boost-margins-and-earnings-says-analyst
Haemonetics' Strategic Moves Poised To Boo...
06/12/2024 17:34:28

Analyst upgrades Haemonetics to Buy, believes company can reach high-20% operating margin goal by FY26 through product mix anal...

this-mccormick-analyst-is-no-longer-bearish-here-are-top-5-upgrades-for-wednesday
This McCormick Analyst Is No Longer Bearis...
06/12/2024 13:45:38

needham-upgrades-haemonetics-to-buy-announces-112-price-target
Needham Upgrades Haemonetics to Buy, Annou...
06/12/2024 09:30:24

Needham analyst Mike Matson upgrades Haemonetics (NYSE:HAE) from Hold to Buy and announces $112 price target.

haemonetics-prices-upsized-private-placement-of-600m-of-250-convertible-senior-notes-due-2029
Haemonetics Prices Upsized Private Placeme...
05/23/2024 10:03:24

haemonetics-announced-525m-convertible-senior-notes-offering
Haemonetics Announced $525M Convertible Se...
05/21/2024 20:41:06

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 20:31:00

4-analysts-assess-haemonetics-what-you-need-to-know
4 Analysts Assess Haemonetics: What You Ne...
05/10/2024 17:01:10

jmp-securities-maintains-market-outperform-on-haemonetics-raises-price-target-to-125
JMP Securities Maintains Market Outperform...
05/10/2024 16:52:14

JMP Securities analyst David Turkaly maintains Haemonetics (NYSE:HAE) with a Market Outperform and raises the price target f...

barrington-research-maintains-outperform-on-haemonetics-raises-price-target-to-107
Barrington Research Maintains Outperform o...
05/10/2024 14:30:02

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target f...

needham-reiterates-hold-on-haemonetics
Needham Reiterates Hold on Haemonetics
05/10/2024 09:50:38

Needham analyst Mike Matson reiterates Haemonetics (NYSE:HAE) with a Hold.

haemonetics-expects-2024-revenue-growth-of-5-8-on-reported-basis-and-0-3-on-organic-basis
Haemonetics Expects 2024 Revenue Growth Of...
05/09/2024 10:59:52

haemonetics-expects-2024-adjusted-eps-of-445-475-versus-consensus-of-440
Haemonetics Expects 2024 Adjusted EPS Of $...
05/09/2024 10:58:40

haemonetics-q4-2024-adj-eps-090-beats-089-estimate-sales-343290m-beat-329113m-estimate
Haemonetics Q4 2024 Adj EPS $0.90 Beats $0...
05/09/2024 10:10:57

barrington-research-maintains-outperform-on-haemonetics-maintains-105-price-target
Barrington Research Maintains Outperform o...
04/12/2024 14:43:30

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and maintains $105 price target.

haemonetics-received-510k-clearance-from-fda-for-teg-6s-hemostasis-analyzer-system-global-hemostasis-hn-assay-cartridge
Haemonetics Received 510(k) Clearance From...
04/04/2024 10:32:27

This new cartridge extends Haemonetics' TEG 6s viscoelastic testing capabilities to serve fully heparinized patients in adu...

haemonetics-agrees-to-acquire-attune-medical-for-an-upfront-cash-payment-of-160m-plus-additional-contingent-consideration-based-on-sales-growth-in-the-three-years
Haemonetics Agrees To Acquire Attune Medic...
03/05/2024 11:02:41

barrington-research-reiterates-outperform-on-haemonetics-maintains-105-price-target
Barrington Research Reiterates Outperform ...
02/13/2024 14:32:39

Barrington Research analyst Michael Petusky reiterates Haemonetics (NYSE:HAE) with a Outperform and maintains $105 price tar...

haemonetics-expects-reported-and-organic-sales-growth-of-10-12-versus-8-10-expected-earlier
Haemonetics Expects Reported And Organic S...
02/08/2024 11:08:21

haemonetics-q3-adjusted-eps-104-beats-094-estimate-sales-33625m-beat-32029m-estimate
Haemonetics Q3 Adjusted EPS $1.04 Beats $0...
02/08/2024 11:02:17

Haemonetics (NYSE:HAE) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.94 by 10....

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)